Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression.
Ben L KongJayne M StommelJamie M KeckDavid KilburnAaron StreblowJulian EggerAllison L CreasonChristopher G SuciuAlexander R GuimaraesChristopher L CorlessGordon B MillsTanja B PejovicPublished in: JCO precision oncology (2024)
Case report of a HER2-expressed ovarian clear cell carcinoma with exceptional response to trastuzumab deruxtecan.